Hypoglycemia Requiring Emergency Services Intervention: Patient Characteristics, Outcome and Cardiovascular Risk Profile
1 other identifier
interventional
323
1 country
1
Brief Summary
Patients who suffer hypoglycaemia in the community requiring the services of an ambulance are known to have a high short term mortality based on previous work. What is not known is the demographics of this group and also what the cause of death was for individuals whom unfortunately passed away in the time following ambulance callout. Importantly, studies looking at interventions to reduce poor outcomes in this group are lacking. The investigators conducted a pilot trial with the main goals to:
- 1.Characterise this group in more detail and ascertain what was recorded as cause of death in those whom passed away in the months/years following community hypoglycaemia
- 2.Ascertain if a simple nurse led intervention, focusing on educating participants on avoidance of hypoglycaemia, could improve outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus
Started Feb 2013
Longer than P75 for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2018
CompletedFirst Submitted
Initial submission to the registry
May 13, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedJune 9, 2020
June 1, 2020
4.9 years
May 13, 2020
June 4, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
All cause mortality at study endpoint with each participant having a minimum follow up of 12 months and the final analysis of data being done 58 months after the first participant was recruited (this is study endpoint.)
Electronic review of participants records to ascertain if they had passed away during the study
Through study endpoint, which was 58 months following the recruitment of the first participant and 12 months following the recruitment of the last participant.
Secondary Outcomes (3)
All cause mortality at 12 months from recruitment.
12 months
Analyse cause of death at study endpoint (12 months following recruitment of last participant).
Study end point defined as 12 months following recruitment of last participant (approximately 40 months from start of study).
Assessment of differences in mortality rate between type 1 and type 2 diabetes participants
Study endpoint (12 months following recruitment of last participant.)
Study Arms (3)
Interventional/intensive
ACTIVE COMPARATORParticipants received a structured nurse led education programme surrounding hypoglycaemia. They were encouraged to use self monitoring of blood glucose (SMBG) and had their diabetes medications adjusted according to this. They also received information on how to avoid hypoglycaemia (including the effects of diet, exercise, alcohol and their medications) and how to treat hypoglycaemia should it occur.
Standard
PLACEBO COMPARATORParticipants returned to their standard diabetes care provider with no intervention.
Observational
NO INTERVENTIONParticipants were happy to have baseline characteristics collected and be followed up using electronic records in a longitudinal fashion but did not wish to be randomized. The observational and standard groups therefore received the same diabetes care.
Interventions
A diabetes research nurse, over a period of 12 months, provided a structured education programme to participants focussing on the avoidance of hypoglycaemia and the treatment of this if/when it occurred.
Participants continue on their current diabetes care plan and are looked after by their usual diabetes care provider
Eligibility Criteria
You may qualify if:
- Diabetes mellitus Can provide written informed consent
You may not qualify if:
- Hypoglycaemia from cause not related to diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leedslead
- Yorkshire Ambulance Service NHS Trustcollaborator
- LifeScancollaborator
Study Sites (1)
Diabetes centre, St James hospital
Leeds, West Yorkshire, LS97TF, United Kingdom
Related Publications (1)
Pearson SM, Whittam B, Kulavarasalingam K, Mitchell-Gears A, James C, Ajjan RA. Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: the role of a pragmatic and structured intervention : Structured intervention for community hypoglycemia. Cardiovasc Diabetol. 2021 Jan 12;20(1):18. doi: 10.1186/s12933-020-01204-3.
PMID: 33435992DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ramzi Ajjan, PHD
Professor of metabolic medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention 9a nurse led education programme) it was not possible to mask participant or trial team to the intervention
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of metabolic medicine
Study Record Dates
First Submitted
May 13, 2020
First Posted
June 9, 2020
Study Start
February 1, 2013
Primary Completion
December 18, 2017
Study Completion
December 18, 2018
Last Updated
June 9, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
No plan to do so is currently in place. Of course once data is submitted if other researchers contact us we would consider providing data for the purpose of meta analysis